Loading organizations...
Loading organizations...
Collaborative venture accelerating drug discovery and novel therapeutics.
Apollo Therapeutics has raised $172.9M across 2 funding rounds.
Apollo Therapeutics has raised $172.9M in total across 2 funding rounds.
Apollo Therapeutics has raised $172.9M in total across 2 funding rounds.
Apollo Therapeutics's investors include Jim Momtazee, M&G Investments, Rock Springs Capital, Reimagined Ventures, UCL Technology Fund.
Apollo Therapeutics has raised $172.9M across 2 funding rounds. Most recently, it raised $33.5M Series C in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 2, 2024 | $33.5M Series C | Jim Momtazee | M&G Investments, Rock Springs Capital |
| Jun 18, 2021 | $139.4M Other Equity | Jim Momtazee | Reimagined Ventures, Rock Springs Capital, UCL Technology Fund |